Global Chronic Lower Back Pain Treatment Market Report and Forecast 2024-2032

Global Chronic Lower Back Pain Treatment Market Outlook

The global chronic lower back pain treatment market size was estimated to be worth USD 8.29 billion in 2023. The market is expected to rise at a CAGR of 4.9% in the forecast period of 2024-2032, and by 2032, the market value is anticipated to be worth USD 12.75 billion. The rise in the neurological disorders and the sedentary lifestyle of the people are the primary market drivers.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Chronic Lower Back Pain: Insights, Aetiology , Diagnosis, and Treatment

Chronic lower back pain is a type of back pain which lasts for a period of twelve weeks and more. This pain continues to persist even after the treatment of acute lower back pain.

Numerous factors account for the aetiology of chronic lower back pain. The main causes of chronic lower back pain are congenital disorders, injuries, degenerative problems, nerve and spinal cord problems. These all causes are mechanical in nature.

The congenital causes include skeletal disorders and spina bifida. Sprains or any type of traumatic injury are also responsible for chronic lower back pain. The non-spinal causes of chronic lower back pain include kidney stones, endometriosis, tumours, fibromyalgia, and pregnancy.

The risk factors of chronic lower back pain include increasing age, smoking, and genetic and psychological factors. Improper lifestyle patterns and improper postures significantly increase the chances of chronic lower back pain.

The diagnosis and management of chronic lower back pain account for the chronic lower back pain treatment market. The diagnostic tests include blood tests, bone scans, and discography. Diagnostic imaging tests, such as computerised tomography, magnetic resonance imaging, and X-ray imaging are also used to assess the body’s anatomy.

Chronic lower back pain is treated through a proper step-by-step procedure. The treatment begins with the essential medications with more effective and advanced approaches.

According to the chronic lower back pain treatment market research report, the market can be categorised into the following segments:

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Pain Type

• Discogenic Pain

• Lumbar Spinal Stenosis

• Sacroiliac Pain

• Facet- Joint Pain

• Radicular Pain

• Muscular Pain

• Others

Market Breakup by Diagnosis

• Clinical History

• Physical Examination

• Imaging Guidelines

• Others

Market Breakup by Treatment Channel

• Public
• Private

Market Breakup by Region

• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Chronic Lower Back Pain Treatment Market Scenario

The increasing prevalence of neurological disorders drives the growth of the chronic lower back pain treatment market. The neurological system consists of the brain and spinal cord, so it directly affects the lower back and cause sensations that stimulate lower back pain. Inactive lifestyle patterns are also contributing to lower back pain.

The increased adoption of painkillers for all pain types also stimulate the market growth to a significant extent. The increased sales of painkillers will facilitate the generation of more significant revenues, aiding the expansion of the market.

Additional factors aiding the growth of the market include the rising incidence of lower back pain cases, increasing healthcare expenditure, and better awareness. According to the National Institute of Neurological disorders and stroke, around 80% of adults experience acute or chronic lower back pain discomfort once in a lifetime.

Regional Outlook

North America Accounts for the Largest Market Share

North American regional market is dominating the chronic lower back pain treatment market owing to the advanced healthcare infrastructure, rising prevalence, and increasing research and development activities.

Asia Pacific is Among the Fastest Growing Region

The Asia Pacific region is anticipated to be the fastest growing region due to increasing developmental activities and the rising geriatric population.

Therapeutic Landscape

Chronic lower back pain is the most prevalent chronic pain disorder. The neuropathic component is responsible for the chronic pain and the rising prevalence of other comorbidities. 

The exact cause or mechanism of chronic lower back pain is not known. Due to this, there are no universally accepted therapeutic interventions. The main aim of the treatment is to alleviate the symptoms and reduce the intensity of pain. For the management of pain, several options are available in the chronic lower back pain treatment market.

Potent Treatment Options: Medications, Physical Therapy Programs, and Surgical Procedures

Chronic lower back pain treatment initiates with anti-inflammatory medications. The physician may also prescribe anticonvulsants, antidepressants, and opioid drugs to manage chronic pain. Along with this, self-management techniques like hot or cold packs and physical exercises can also be incorporated into the treatment schedule for more effective results.

Complementary and alternative management techniques like acupuncture, transcutaneous electrical nerve stimulation, spinal mobilisation and physical therapy programs are used to restore mobility and reduce pain sensations. Spinal injections carrying suitable medications can also be given for immediate pain relief.

Surgical procedures are considered for specific indications when the above treatment methods fail. The different surgeries for management of chronic lower back pain are vertebroplasty, spinal laminectomy, discectomy, foraminotomy and nucleoplasty.

Over the last decade, developments in back pain therapies have accelerated and resulted in multiple effective treatment options. These novel therapies and strategies have grabbed the attention of the key players. This will assist in the growth of the chronic lower back pain treatment market.

Clinical Trial Landscape

Technological advancements and extensive clinical research contribute to discovering more innovative therapeutic methods. The trials for the novel medications are under process and, once completed, will lead to the development of novel targeted therapies.

Emerging Therapeutic Options Under Pipeline

A randomised clinical trial was performed by the scientists of the United States, Europe, and Australia to assess the efficacy of their novel method called RESOLVE. This new program is called the graded sensorimotor retraining intervention. In this program, brain-back communication is improved by retraining the brain. The results suggested that this helps decrease the pain intensity of the lower back.

Eli Lilly and Company, one of the leading key players, is also performing Phase II clinical trials for its novel medication that effectively manages chronic back pain. This drug acts by blocking the potent cation channels, thus suppressing the pain sensations.

The incorporation of advanced technologies has also stimulated the development of effective treatments. Abbott, a key player, has successfully performed clinical trials for its new Proclaim Plus spinal cord stimulation system. This system will mimic the natural patterns found in the brain and will assist in pain management.

Several ongoing clinical trials are emerging as a driving factor for chronic lower back pain treatment market growth and development.

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Johnson & Johnson

• Pfizer Inc.

• Sanofi S.A.

• Merck & Co., Inc.

• Medtronic plc

• Endo International plc

• Boston Scientific Corporation

• Koninklijke Philips N.V.

• Karl Storz SE & Co. KG

• Stryker Corporation

Key Highlights of the Report